-

BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2025

ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. (OTC Pink: BIOQ) www.bioqual.com:

Six Months Ended

 

Three Months Ended

November 30,

 

November 30,

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

Revenue

$

23,165,920

 

$

31,448,326

$

11,395,438

 

$

15,869,404

(Loss) Income Before Income Tax

$

(2,604,227

)

$

1,909,744

 

$

(1,672,402

)

$

668,561

 

Net (Loss) Income

$

(1,887,527

)

$

1,384,144

 

$

(1,212,202

)

$

484,661

 

Basic Earnings per Share

of Common Stock

$

(2.11

)

$

1.55

 

$

(1.36

)

$

0.54

 

Diluted Earnings per Share

of Common Stock

$

(2.11

)

$

1.55

 

$

(1.36

)

$

0.54

 

Weighted Average

Number of Shares Outstanding

 

 

For Basic Earnings Per Share

 

894,416

 

 

894,416

 

 

894,416

 

 

894,416

 

Weighted Average

Number of Shares Outstanding

For Diluted Earnings Per Share

 

894,399

 

 

894,398

 

 

894,394

 

 

894,390

 

 

 

For more detail related to the fiscal year 2025 unaudited second quarter results, please visit our web site at www.bioqual.com.

 

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Company’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including risks relating to the ability to continue to extend current government contracts; the Company’s ability to obtain new government and commercial contracts; continued demand for the use of animal models in scientific research; the Company’s ability to obtain sufficient numbers of animal models; the availability of adequate numbers of employees; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company’s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.

Contacts

Mark G. Lewis, Ph.D., CEO (240-404-7654)

BIOQUAL, Inc.

OTC Pink:BIOQ

Release Versions

Contacts

Mark G. Lewis, Ph.D., CEO (240-404-7654)

More News From BIOQUAL, Inc.

BIOQUAL Announces Retirement of Mike O'Flaherty From Board

ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pinksheets) BIOQUAL, Inc., announced today that Mr. Michael P. O’Flaherty will retire from his role as a BIOQUAL Board Member effective May 1, 2025. Mr. O’Flaherty served as the Chief Operating Officer and Secretary of the Corporation until he retired in 2015 at which time he was elected to the BIOQUAL Board. Mr. O’Flaherty is 86 years old and has served as a Director since 2015. His retirement is not connected to any disagreem...

BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2025

ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. (OTC Pink: BIOQ) www.bioqual.com:   Nine Months Ended Three Months Ended   February 28 & 29, February 28 & 29,     2025     2024   2025   2024   Revenue $ 37,198,902   $ 46,792,353 $ 14,032,982 $ 15,344,027     (Loss) Income Before Income Tax $ (1,312,897 ) $ 2,288,970 $ 1,291,330 $ 379,226     Net (Loss) Income $ (951,497 ) $ 1,659,170 $ 936,030 $ 275,026     Basic Earnings per Share   of Common Stock $ (1.06 ) $ 1.86 $ 1.05 $ 0.31     Dil...

BIOQUAL Announces Changes to Board of Directors

ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pinksheets) BIOQUAL, Inc., announced today that Mr. Charles Francisco retired from his role as a BIOQUAL Board Member effective December 31, 2024. Mr. Francisco is 85 years old and has served as a director since 1992. His retirement is not connected to any disagreements with the Board’s policies or practices. Additionally, on December 31, 2024 BIOQUAL welcomed Ms. Amy Johnston to the BIOQUAL Board of Directors. Ms. Johnston wil...
Back to Newsroom